GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for EpiDREAM

EpiDREAM

Official Title

Epidemiologic study of the Screenes for DREAM (Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication)

Status

Completed

Study Design

Cohort study

Primary Endpoint

Diabetes and CVD

Number of Patients

18990

Number of Sites

191

Number of Countries

21

Study Period

2001–2008

Principal Investigator

Sonia Anand

Program Manager

Jackie Bosch

Research Coordinator

Dipika Desai

Collaborators

CIHR; HSFO; GSK; Sanofi-Aventis

Key Publications

  • Anand S, Dagenais G, Mohan V, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Preventive Cardiol. 2012;19:755–764